Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia.

Source:http://linkedlifedata.com/resource/pubmed/id/11240824

Download in:

View as

General Info

PMID
11240824